Cargando…

Targeted therapy and immunotherapy: Diamonds in the rough in the treatment of epithelial ovarian cancer

Currently, for ovarian cancer, which has the highest mortality rate among all gynecological cancers, the standard treatment protocol is initial tumor cytoreductive surgery followed by platinum-based combination chemotherapy. Although the survival rate after standard treatment has improved, the thera...

Descripción completa

Detalles Bibliográficos
Autores principales:	Huang, Xu, Li, Xiao-Yu, Shan, Wu-Lin, Chen, Yao, Zhu, Qi, Xia, Bai-Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080064/ https://www.ncbi.nlm.nih.gov/pubmed/37033645 http://dx.doi.org/10.3389/fphar.2023.1131342

Ejemplares similares

Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy
por: Clappaert, Emile J., et al.
Publicado: (2018)

Progress and prospects of targeted therapy and immunotherapy for urachal carcinoma
por: Zheng, Yang, et al.
Publicado: (2023)

Editorial: Ovarian cancer-targeted medication: PARP inhibitors, anti-angiogenic drugs, immunotherapy, and more
por: Wang, Zhi-Bin, et al.
Publicado: (2023)

Potential Application of Pyroptosis in Kidney Renal Clear Cell Carcinoma Immunotherapy and Targeted Therapy
por: Qi, Xiaochen, et al.
Publicado: (2022)

Potential targets and applications of nanodrug targeting myeloid cells in osteosarcoma for the enhancement of immunotherapy
por: Zhu, Jianshu, et al.
Publicado: (2023)

Advances in Targeted Therapy and Immunotherapy for Non-small Cell Lung Cancer Based on Accurate Molecular Typing
por: Dong, Jingsi, et al.
Publicado: (2019)

Pyroptosis-related genes prognostic model for predicting targeted therapy and immunotherapy response in soft tissue sarcoma
por: Liu, Mengmeng, et al.
Publicado: (2023)

Identification of a novel ferroptosis-related gene signature associated with prognosis, the immune landscape, and biomarkers for immunotherapy in ovarian cancer
por: Liu, Yilong, et al.
Publicado: (2022)

Immunotherapy and targeted therapy for lung cancer: Current status and future perspectives
por: Zulfiqar, Bilal, et al.
Publicado: (2022)

Rough diamonds: a collection of leadership gems from the vault
por: Mitchell, Paul
Publicado: (2020)

Krupple-Like Factor 5 is a Potential Therapeutic Target and Prognostic Marker in Epithelial Ovarian Cancer
por: Siraj, Abdul K., et al.
Publicado: (2020)

Editorial: Targeted Immunotherapy for Cancer
por: Williams, Williams V.
Publicado: (2022)

Immunotherapy targeting cytokines in neuropathic pain
por: Lees, Justin G., et al.
Publicado: (2013)

Molecular Dynamics Investigation of Residual Stress and Surface Roughness of Cerium under Diamond Cutting
por: Li, Yao, et al.
Publicado: (2018)

β-Glucan Combined With PD-1/PD-L1 Checkpoint Blockade for Immunotherapy in Patients With Advanced Cancer
por: Wang, Mengjie, et al.
Publicado: (2022)

Rough Diamonds: The Four Traits of Successful Breakout Firms in BRIC Countries
por: Park, Seung
Publicado: (2013)

Rough Diamond: A Carbon Isotopic Biomarker of Added Sugar Intake
por: O'Connell, Tamsin C
Publicado: (2020)

Bioresorbable Vascular Scaffolds—Dead End or Still a Rough Diamond?
por: Jeżewski, Mateusz P., et al.
Publicado: (2019)

Cationic Organophosphorus Chromophores: A Diamond in the Rough among Ionic Dyes
por: Belyaev, Andrey, et al.
Publicado: (2020)

A diamond in the rough: computational flow modeling of fenestrated stent repair
por: Tillman, Bryan W.
Publicado: (2021)

Diamonds in the not-so-rough: Wild relative diversity hidden in crop genomes
por: Flint-Garcia, Sherry, et al.
Publicado: (2023)

Tribological Performance of Diamond Films with Different Roughnesses of Silicon Nitride Substrates and Carbon Source Concentrations
por: Lu, Feng, et al.
Publicado: (2022)

FBXO22 Promotes Growth and Metastasis and Inhibits Autophagy in Epithelial Ovarian Cancers via the MAPK/ERK Pathway
por: Li, Minle, et al.
Publicado: (2021)

Nanoscale Diamond-Based Formulation as an Immunomodulator and Potential Therapeutic for Lymphoma
por: Paladhi, Ankush, et al.
Publicado: (2022)

Identification and validation of roles of lysyl oxidases in the predictions of prognosis, chemotherapy and immunotherapy in glioma
por: Xia, Qin-Xuan, et al.
Publicado: (2022)

Nanoparticles with rough surface improve the therapeutic effect of photothermal immunotherapy against melanoma
por: Xue, Jiao, et al.
Publicado: (2022)

Progress of research on molecular targeted therapies for colorectal cancer
por: Huang, Shilin, et al.
Publicado: (2023)

Bevacizumab loaded CalliSpheres® bronchial arterial chemoembolization combined with immunotherapy and targeted therapy for advanced lung adenocarcinoma
por: Liu, Haitao, et al.
Publicado: (2023)

Surface Roughness after Milling of the Al/CFRP Stacks with a Diamond Tool
por: Doluk, Elżbieta, et al.
Publicado: (2021)

The current trend of exosome in epithelial ovarian cancer studies: A bibliometric review
por: Baghban, Neda, et al.
Publicado: (2023)

Myricetin suppresses TGF-β-induced epithelial-to-mesenchymal transition in ovarian cancer
por: Yang, Hui-Wen, et al.
Publicado: (2023)

Molecular targeted therapy for metastatic colorectal cancer: current and evolving approaches
por: Li, Furong, et al.
Publicado: (2023)

Comprehensive bioinformatic analysis constructs a CXCL model for predicting survival and immunotherapy effectiveness in ovarian cancer
por: Li, Shuang, et al.
Publicado: (2023)

Editorial: Crosstalk between cancer-associated fibroblasts and tumor cells in the tumor microenvironment: an emerging target of anti-cancer immunotherapy
por: Zhang, Chunxue, et al.
Publicado: (2023)

Research progress of interleukin-15 in cancer immunotherapy
por: Cai, Menghan, et al.
Publicado: (2023)

Chronic inflammation, cancer development and immunotherapy
por: Wen, Yalei, et al.
Publicado: (2022)

Safety Profile of Immunotherapy Combined With Antiangiogenic Therapy in Patients With Melanoma: Analysis of Three Clinical Studies
por: Tian, Hui, et al.
Publicado: (2021)

Immunotherapy Advances for Epithelial Ovarian Cancer
por: Hartnett, Erin G., et al.
Publicado: (2020)

Immunotherapy for Ovarian Cancer: Adjuvant, Combination, and Neoadjuvant
por: Yang, Chang, et al.
Publicado: (2020)

The Top 100 Highly Cited Original Articles on Immunotherapy for Childhood Leukemia
por: Zhong, Qing, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ac3t2lsdlvmhi4o561pfggrs9e